Galectin Therapeutics Inc (NASDAQ:GALT)

2.63
Delayed Data
As of Jul 27
 -0.06 / -2.23%
Today’s Change
2.50
Today|||52-Week Range
16.20
-24.21%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.69
Today’s open2.70
Day’s range-- - --
Volume76,428
Average volume (3 months)175,224
Market cap$62.4M
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-15.38%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
GBSNUGreat Basin Scientif...-0.32-1.96%
ERBERBA Diagnostics Inc+0.02+1.05%
TROVUTrovagene Inc0.000.00%
TTHITransition Therapeut...-0.00-0.00%
Data as of 07/27/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers